Company
Denali Therapeutics Inc (NASDAQ: DNLI): Stock Forecast For 2025 Remains Weak With A Downward Revision Of 35.3%
In the last trading session, 2.81 million shares of the Denali Therapeutics Inc (NASDAQ:DNLI) were traded, and its beta was 1.55. Most recently the company’s
